Evaluation of a New Treatment for Migraine Attacks
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The purpose of this study is to evaluate the efficacy of a novel therapy for treatment of migraine, pain reduction and relief of associated symptoms during ongoing migraine attacks, and presence of a preventive effect post treatment.
Condition or disease
Device: Inactive Migraine Medical DeviceDevice: Migraine Medical Device
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
20 Years to 55 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Female or male subjects, in otherwise good health, 20 to 55 years of age
Subjects who meet the ICHD-2 (2nd Edition of The International Headache Classification) criteria for migraine headache
Subjects with a minimum of 1 migraine attack per month
Attack duration of 4 to 72 hours
Normal attack intensity of at least 4 on a 0-10 VAS-scale